Share this article

print logo

IPOs / Week of Jan. 30

The following is a list of initial public offerings planned for the coming week. Sources include SEC filings and Renaissance Capital, Greenwich, Conn. (www.renaissancecapital.com).

AcelRx Pharmaceuticals

(Redwood City, Calif.) 5.8 million shares, priced $12 to $14, managed by Piper Jaffray. Proposed Nasdaq symbol: ACRX. Business: Biotech developing a Phase 3 treatment for acute post-operative pain.

BioHorizons Inc.

(Birmingham, Ala.) 5.6 million shares, priced $15 to $17, managed by Piper Jaffray and Jefferies & Co. Proposed Nasdaq symbol: BHZN. Business: Sells dental implants and biologics for the replacement of missing teeth.

China Century Dragon Media

(Huizhou City, China) 1.4 million shares, priced, $6 to $7, managed by WestPark Capital and i-Bankers Securities. Proposed NYSE Amex symbol: CDM. Business: TV advertising company that resells ad time on China Central Television.

Endocyte Inc.

(West Lafayette, Ind.) 5.4 million shares, priced $13 to $15, managed by RBC Capital Markets and Leerink Swann. Proposed Nasdaq symbol: ECYT. Business: Is developing EC145 (entering Phase III) for the treatment of ovarian cancer.

Epocrates Inc.

(San Mateo, Calif.) 5.4 million shares, priced $13 to $15, managed by J.P. Morgan and Piper Jaffray. Proposed Nasdaq symbol: EPOC. Business: Provides an ad-supported mobile drug reference app for health care professionals.

Imperial Holdings

(Boca Raton, Fla.) 16.7 million shares, priced $14 to $16, managed by FBR Capital Markets, JMP Securities, and Wunderlich Securities. Proposed NYSE symbol: IFT. Business: Specialty finance company originating loans collateralized by life insurance policies.

MedQuist Holdings

(Franklin, Tenn.) 7.8 million shares, priced $10 to $12, managed by Lazard Capital Markets, Macquarie Capital, and RBC Capital Markets. Proposed Nasdaq symbol: MEDH. Business: Provides integrated clinical documentation solutions to over 2,400 hospitals and clinics in the US.

NeoPhotonics Corp.

(San Jose, Calif.) 7 million shares, priced $9 to $11, managed by BofA Merrill Lynch and Deutsche Bank. Proposed NYSE symbol: NPTN. Business: Leading supplier of photonic-based optical modules and subsystems.

Pacira Pharmaceuticals

(Parsippany, N.J.) 4.3 million shares, priced $14 to $16, managed by Barclays and Piper Jaffray. Proposed Nasdaq symbol: PCRX. Business: Developing a non-opioid postsurgical analgesic pending FDA approval.

Tornier N.V.

(The Netherlands) 8.8 million shares, priced $19 to $21, managed by BofA Merrill Lynch, and J.P. Morgan. Proposed Nasdaq symbol: TRNX. Business: Makes orthopedic implants for upper and lower extremity joints.

Trunkbow International Holdings Ltd.

(Beijing, China) 5 million shares, priced $5 to $7, managed by Roth Capital. Proposed Nasdaq symbol: TBOW. Business: Provider of mobile applications to telecom operators.

There are no comments - be the first to comment